The surge in revenue is linked to the heightened sales of ethical products, including infusions, capsules, and tablets.
Fidelis Ayebae
-
-
Ayebae, a banker turned accomplished industrialist, owns a 33.1-percent stake in the pharmaceutical company, which translates to 759,643,749 ordinary shares.
-
The recent gains solidify Ayebae’s position as one of Africa’s pharmaceutical industry magnates.
-
Ayebae owns an impressive 33.1-percent stake in Fidson Healthcare.
- West & Central Africa
Nigerian pharma tycoon Fidelis Ayebae’s stake in Fidson is now worth $14.8 million
Under Ayebae’s guidance, Fidson Healthcare has achieved exceptional financial growth, reporting a significant increase in profits for the 2022 fiscal year.
- Hot News
Nigerian pharma tycoon Fidelis Ayebae’s Fidson smashes expectations with $9.08-million profit
Fidson Healthcare has established itself as a leading player in the Nigerian and West African pharmaceutical industries.